Nothing Special   »   [go: up one dir, main page]

AU2090099A - Reduction of uv induced skin cancer by topical amines - Google Patents

Reduction of uv induced skin cancer by topical amines

Info

Publication number
AU2090099A
AU2090099A AU20900/99A AU2090099A AU2090099A AU 2090099 A AU2090099 A AU 2090099A AU 20900/99 A AU20900/99 A AU 20900/99A AU 2090099 A AU2090099 A AU 2090099A AU 2090099 A AU2090099 A AU 2090099A
Authority
AU
Australia
Prior art keywords
topical
amines
reduction
skin cancer
induced skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU20900/99A
Inventor
William Darwin Garner
Martin J. Griffin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2090099A publication Critical patent/AU2090099A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89—Polysiloxanes
    • A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU20900/99A 1997-12-16 1998-12-15 Reduction of uv induced skin cancer by topical amines Abandoned AU2090099A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US6971397P 1997-12-16 1997-12-16
US60069713 1997-12-16
US9146498P 1998-07-01 1998-07-01
US60091464 1998-07-01
PCT/US1998/027261 WO1999030705A1 (en) 1997-12-16 1998-12-15 Reduction of uv induced skin cancer by topical amines

Publications (1)

Publication Number Publication Date
AU2090099A true AU2090099A (en) 1999-07-05

Family

ID=26750344

Family Applications (1)

Application Number Title Priority Date Filing Date
AU20900/99A Abandoned AU2090099A (en) 1997-12-16 1998-12-15 Reduction of uv induced skin cancer by topical amines

Country Status (2)

Country Link
AU (1) AU2090099A (en)
WO (1) WO1999030705A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994409A (en) 1997-12-09 1999-11-30 U.S. Bioscience, Inc. Methods for treatment of neuro--and nephro--disorders and therapeutic toxicities using aminothiol compounds
US6489312B1 (en) 1999-06-15 2002-12-03 Medimmune Oncology, Inc. Pharmaceutical formulations comprising aminoalkyl phosphorothioates
US6365215B1 (en) * 2000-11-09 2002-04-02 International Flavors & Fragrances Inc. Oral sensory perception-affecting compositions containing dimethyl sulfoxide, complexes thereof and salts thereof
US7053072B2 (en) 2001-05-11 2006-05-30 Medimmune Oncology, Inc. Methods for the administration of amifostine and related compounds
EP1753425A4 (en) * 2004-05-12 2009-08-05 Biorunx Co Ltd A therapeutic agent containing nicotinic acid or its derivatives as an effective ingredient for prevention and treatment of cancer
IL303136A (en) * 2020-11-25 2023-07-01 F3 Platform Biologics Inc : compositions and uses of same for preventing and protecting against damage in cells and tissues

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4378364A (en) * 1970-05-05 1983-03-29 Grassetti Davide R Postoperative treatment of carcinoma patients
US5290813A (en) * 1987-06-04 1994-03-01 Massachusetts Institute Of Technology Chemical prevention or reversal of cataract by phase separation inhibitors
JP2637534B2 (en) * 1987-10-28 1997-08-06 プロ−ニューロン，インコーポレーテッド Acyldeoxyribonucleoside derivatives and uses thereof
IL121789A (en) * 1996-10-03 2001-06-14 Rohm & Haas Pharmaceutical composition for inhibiting mammalian cell growth

Also Published As

Publication number Publication date
WO1999030705A1 (en) 1999-06-24

Similar Documents

Publication Publication Date Title
AU7859800A (en) Topical nasal treatment
AU5087199A (en) Method of treating topical ailments
EE04390B1 (en) Topical preparation for the treatment of dermatological conditions
AU1200499A (en) Elisa for interstitial cystitis and bladder cancer
AU9403798A (en) Human regulatory molecules
AU1958897A (en) Egf-genistein conjugates for the treatment of cancer
EP1176964B8 (en) Uses of et743 for treating cancer
AUPQ877300A0 (en) Topical treatment of skin
HUP9900905A3 (en) Use of vitamin d4 derivatives for treating cancer
AU1784301A (en) Topical skin composition
AU1773600A (en) Topical treatment of skin disease
AU2991299A (en) Monoterpenoid derivatives for treatment of cancer
AU5988896A (en) Topical composition for fungal treatment
AU1184399A (en) Therapeutic molecules
GB9918760D0 (en) Topical treatment
AU1480497A (en) Cancer treatment
AU3082401A (en) Therapy of psoriasis
GB9509572D0 (en) Cancer therapy
AU2964495A (en) Vicinal-substituted carbocyclic compounds as therapeutic agents
AU2090099A (en) Reduction of uv induced skin cancer by topical amines
ZA969147B (en) Application of the gax protein to the treatment of cancer
AU7636800A (en) Improved ricin-like toxins for treatment of cancer
AU5552400A (en) Treatment of cancer
AUPQ367699A0 (en) Treatment of cancer
GB9703633D0 (en) Cancer therapy

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase